Literature DB >> 23832137

Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schönlein purpura nephritis.

Jean-Claude Davin, Rosanna Coppo.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23832137     DOI： 10.1007/s00467-013-2550-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  38 in total

1.  Addition of plasma exchange to glucocorticosteroids for the treatment of severe Henoch-Schönlein purpura in adults: a case series.

Authors:  Jean-François Augusto; Johnny Sayegh; Laurence Delapierre; Anne Croue; Fréderic Tollis; Maud Cousin; Jean-François Subra
Journal:  Am J Kidney Dis       Date:  2012-01-31       Impact factor: 8.860

2.  Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura.

Authors:  Evangéline Pillebout; Corinne Alberti; Loic Guillevin; Amel Ouslimani; Eric Thervet
Journal:  Kidney Int       Date:  2010-05-26       Impact factor: 10.612

3.  Anaphylactoid purpura.

Authors:  W H Borges
Journal:  Med Clin North Am       Date:  1972-01       Impact factor: 5.456

4.  Schönlein-Henoch nephritis.

Authors:  S R Meadow; E F Glasgow; R H White; M W Moncrieff; J S Cameron; C S Ogg
Journal:  Q J Med       Date:  1972-07

5.  Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis.

Authors:  Hiroshi Tanaka; Koichi Suzuki; Tohru Nakahata; Etsuro Ito; Shinobu Waga
Journal:  Pediatr Nephrol       Date:  2003-03-28       Impact factor: 3.714

6.  Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein purpura nephritis.

Authors:  Yukihiko Kawasaki; Kazuhide Suyama; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Clin Rheumatol       Date:  2010-09-16       Impact factor: 2.980

7.  Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome.

Authors:  R F Andersen; S Rubak; B Jespersen; S Rittig
Journal:  Scand J Urol Nephrol       Date:  2009

8.  Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide.

Authors:  Penina Tarshish; Jay Bernstein; Chester M Edelmann
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

9.  Prognostic significance of the glomerular changes in Henoch-Schoenlein nephritis.

Authors:  N Yoshikawa; R H White; A H Cameron
Journal:  Clin Nephrol       Date:  1981-11       Impact factor: 0.975

10.  A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura [ISRCTN85109383].

Authors:  Adam M Huber; Jim King; Peter McLaine; Terry Klassen; Mary Pothos
Journal:  BMC Med       Date:  2004-04-02       Impact factor: 8.775
View more
  18 in total

1.  The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis.

Authors:  Mikael Koskela; Elisa Ylinen; Elli-Maija Ukonmaanaho; Helena Autio-Harmainen; Päivi Heikkilä; Jouko Lohi; Outi Jauhola; Jaana Ronkainen; Timo Jahnukainen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

2.  Mycophenolate mofetil following glucocorticoid treatment in Henoch-Schönlein purpura nephritis: the role of early initiation and therapeutic drug monitoring.

Authors:  Agnes Hackl; Jan U Becker; Lisa M Körner; Rasmus Ehren; Sandra Habbig; Eva Nüsken; Kai-Dietrich Nüsken; Kathrin Ebner; Max C Liebau; Carsten Müller; Martin Pohl; Lutz T Weber
Journal:  Pediatr Nephrol       Date:  2017-11-25       Impact factor: 3.714

3.  Histological prognostic factors in children with Henoch-Schönlein purpura nephritis.

Authors:  Jean-Daniel Delbet; Guillaume Geslain; Martin Auger; Julien Hogan; Rémi Salomon; Michel Peuchmaur; Georges Deschênes; David Buob; Cyrielle Parmentier; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2019-11-06       Impact factor: 3.714

4.  Does MEST-C score predict outcomes in pediatric Henoch-Schönlein purpura nephritis?

Authors:  Adam Jimenez; Ashton Chen; Jen-Jar Lin; Andrew M South
Journal:  Pediatr Nephrol       Date:  2019-08-11       Impact factor: 3.714

5.  Henoch-Schönlein purpura in children: Use of corticosteroids for prevention and treatment of renal disease.

Authors:  Amir Gohari; Douglas G Matsell; Cherry Mammen; Ran D Goldman
Journal:  Can Fam Physician       Date:  2020-12       Impact factor: 3.275

Review 6.  Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management.

Authors:  Jun-Yi Chen; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2014-12-29       Impact factor: 2.764

7.  Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.

Authors:  Jean Daniel Delbet; Julien Hogan; Bilal Aoun; Iulia Stoica; Rémi Salomon; Stéphane Decramer; Isabelle Brocheriou; Georges Deschênes; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2017-02-15       Impact factor: 3.714

8.  Efficacy and Safety of Tacrolimus in the Treatment of Pediatric Henoch-Schönlein Purpura Nephritis.

Authors:  Dengyan Wu; Rui Ma; Xingmin Wang; Yonghong Yang
Journal:  Paediatr Drugs       Date:  2022-05-05       Impact factor: 3.022

Review 9.  Henoch-Schönlein purpura nephritis.

Authors:  Martin Pohl
Journal:  Pediatr Nephrol       Date:  2014-04-15       Impact factor: 3.714

10.  Determination of Risk Factors in Children Diagnosed With Henoch-Schönlein Purpura.

Authors:  Beltinge Demircioğlu Kiliç; Belde Kasap Demir
Journal:  Arch Rheumatol       Date:  2018-01-30       Impact factor: 1.472
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.